Access Terms
Confidentiality & Access Summary
NURI Investor Pitch
v0.9 Pre-Release
TTD · 2026
By accessing this pitch environment you acknowledge and agree to the terms below. This is a summary only — not a substitute for a formal NDA. If a signed NDA has been issued separately, it takes precedence over this summary in all respects.
01
Confidentiality Obligation
All information presented within this environment — including but not limited to product architecture, clinical workflows, commercial terms, funding details, regulatory strategy, and team composition — is proprietary and strictly confidential to Teh Tarik Digital. You may not share, reproduce, distribute, or disclose any portion of this material to any third party without prior written consent from TTD.
02
Clinical Data Disclaimer
All patient scenarios, clinical records, bed assignments, vital sign readings, NEWS2 scores, and clinical notes presented within the demonstration environment are entirely synthetic and fabricated for illustrative purposes only. No real patient records, clinical encounters, or personally identifiable health information of any kind were used in the creation of this material. Any resemblance to actual patients or clinical events is coincidental and unintended.
Important: The simulated clinical environment displayed within this pitch does not represent a live, operational, or regulated medical system. It is a demonstration prototype only and must not be relied upon for any clinical, diagnostic, or medical purpose.
03
Software as a Medical Device (SaMD) Status
NURI is currently in active pre-clinical validation phase as a Clinical Decision Support System (CDSS) operating under investigational use conditions only. Nothing presented within this pitch environment constitutes:
- A representation that NURI holds current MDA registration or regulatory approval in any jurisdiction
- Medical advice, clinical guidance, or endorsement of any clinical practice
- A warranty of clinical accuracy, diagnostic validity, or patient safety outcomes
NURI's regulatory pathway — including classification assessment and MDA filing — is in progress. All regulatory timelines stated in this pitch are projections subject to regulatory review outcomes.
Reference: Medical Device Act 2012 (Act 737) · Malaysian Medical Device Authority (MDA) · MOH Clinical Practice Guidelines
04
Forward-Looking Statements
Financial projections, market sizing estimates, pilot timelines, revenue forecasts, and commercial terms presented in this pitch are forward-looking in nature. They are based on current assumptions and are subject to material change. They do not constitute a guarantee of future performance or returns.
05
Authorised Use Only
Access to this environment is granted exclusively to the individual or organisation to whom an access code was directly issued by TTD. Codes must not be shared. TTD reserves the right to revoke access at any time without notice. Unauthorised access or sharing of this material may give rise to legal liability under applicable law including but not limited to the Companies Act 2016, Trade Secrets Act, and Personal Data Protection Act 2010.